healthy ones, enhancing specificity for target cells, and regulating drug expression post-administration. Senti's Gene Circuits have been demonstrated in preclinical studies to be effective in both NK and T cells. Additionally, Senti Bio has shown in preclinical research the potential applicability of Gene Circuits in a variety of other treatment areas and diseases beyond oncology, and is actively progressing these efforts through partnerships.